ArticleFrontiers in pharmacology2022

Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure.

Runzhen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.